Jeffrey Nau | President and CEO |
Daniel Lochner | CFO |
John Snisarenko | Chief Commercial Officer |
Stacy Ku | Cowen and Company |
Good evening and welcome to Oyster Point Pharma's third-quarter 2020 earnings conference call. My name is Dilem, and I'll be your operator today. [Operator instructions] I'd like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma's chief financial officer. Sir, please go ahead.